| RS1798086782 |
IMPDH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 11, Retinitis pigmentosa 10 |
| RS1798090339 |
IMPDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa 10 |
| RS1798090540 |
IMPDH1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 11, Retinal dystrophy |
| RS1798091523 |
IMPDH1
|
Health Risk |
Pathogenic |
— |
| RS1798091848 |
PLOD3
|
Health Risk |
Pathogenic |
Bone fragility with contractures, arterial rupture |
| RS1798139951 |
CEP41
|
Health Risk |
Pathogenic |
Joubert syndrome 15, Joubert syndrome 15 |
| RS1798140230 |
KMT2E
|
Health Risk |
Likely pathogenic |
— |
| RS1798145890 |
KMT2E
|
Health Risk |
Pathogenic |
— |
| RS1798216037 |
IMPDH1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1798228728 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1798241938 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1798243790 |
RUNX2
|
Health Risk |
Likely pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS1798246011 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1798255831 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS1798258547 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1798259380 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS1798261271 |
RUNX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS1798262516 |
RUNX2
|
Health Risk |
Likely pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS1798379068 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1798467599 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1798487766 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS1798490375 |
SLC25A13
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrin deficiency, Citrullinemia |
| RS1798504836 |
IMPDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1798520770 |
COG5
|
Health Risk |
Pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS1798551566 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS1798601140 |
EYA4
|
Health Risk |
Pathogenic |
EYA4-related disorder, Dilated cardiomyopathy 1J |
| RS1798679896 |
KMT2E
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, O'Donnell-Luria-Rodan syndrome |
| RS1798733144 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS1798735440 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS1798736907 |
RUNX2
|
Health Risk |
Likely pathogenic |
— |
| RS1798791092 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1798849948 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
CFTR-related disorder, Cystic fibrosis |
| RS1798854245 |
CFTR
|
Health Risk |
Pathogenic |
— |
| RS1798854379 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1798858347 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1798890807 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1798939855 |
KMT2E
|
Health Risk |
Likely pathogenic |
O'Donnell-Luria-Rodan syndrome, O'Donnell-Luria-Rodan syndrome |
| RS1798957076 |
KMT2E
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1798959540 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1798962805 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1798964448 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1798970889 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1798970895 |
KMT2E
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1798979994 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1799022949 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1799061745 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1799182705 |
KMT2E
|
Health Risk |
Conflicting classifications of pathogenicity |
O'Donnell-Luria-Rodan syndrome, O'Donnell-Luria-Rodan syndrome |
| RS1799183455 |
KMT2E
|
Health Risk |
Likely pathogenic |
O'Donnell-Luria-Rodan syndrome, O'Donnell-Luria-Rodan syndrome |
| RS1799200073 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS1799201805 |
KMT2E
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1799216615 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1799307071 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS1799325384 |
RPGR
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1799374421 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS1799378709 |
KMT2E
|
Health Risk |
Pathogenic/Likely pathogenic |
O'Donnell-Luria-Rodan syndrome, O'Donnell-Luria-Rodan syndrome |
| RS1799386566 |
KMT2E
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1799402262 |
KMT2E
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1799414845 |
KMT2E
|
Health Risk |
Conflicting classifications of pathogenicity |
KMT2E-related disorder, Inborn genetic diseases |
| RS1799418948 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1799421850 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, CFTR-related disorder |
| RS1799425190 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Hereditary pancreatitis |
| RS1799458667 |
DOCK4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1799463371 |
TNPO3
|
Health Risk |
Likely pathogenic |
— |
| RS1799515896 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1799516672 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1799544883 |
SLC25A46
|
Health Risk |
Pathogenic |
Neuropathy, hereditary motor and sensory |
| RS1799563986 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1799588164 |
SGCE
|
Health Risk |
Pathogenic |
— |
| RS1799652893 |
SSBP1
|
Health Risk |
Pathogenic |
Optic atrophy 13 with retinal and foveal abnormalities, Cone-rod dystrophy |
| RS1799653139 |
SSBP1
|
Health Risk |
Likely pathogenic |
Optic atrophy 13 with retinal and foveal abnormalities, Optic atrophy 13 with retinal and foveal abnormalities |
| RS1799660837 |
MEF2C
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS1799692515 |
ASAH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1799724 |
TNF
|
Health Risk |
risk factor |
— |
| RS1799735312 |
ASAH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1799747454 |
SSBP1
|
Health Risk |
Pathogenic |
Optic atrophy 13 with retinal and foveal abnormalities, Retinal disorder |
| RS1799762 |
SERPINE1
|
Health Risk |
Pathogenic; other |
Transcription level of plasminogen activator inhibitor 1, Transcription level of plasminogen activator inhibitor 1 |
| RS1799780 |
XRCC1
|
Health Risk |
association |
Laryngeal squamous cell carcinoma, Laryngeal squamous cell carcinoma |
| RS1799792 |
ERCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group D |
| RS1799802 |
ERCC4
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group F |
| RS1799807 |
BCHE
|
Health Risk |
Pathogenic/Likely pathogenic |
Postanesthetic apnea, Deficiency of butyrylcholinesterase |
| RS1799812 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1799815535 |
SLC25A46
|
Health Risk |
Likely pathogenic |
Neuropathy, hereditary motor and sensory |
| RS1799816 |
INSR
|
Health Risk |
Conflicting classifications of pathogenicity |
Type 2 diabetes mellitus, Insulin-resistant diabetes mellitus AND acanthosis nigricans |
| RS1799819389 |
SLC25A46
|
Health Risk |
Pathogenic |
Neuropathy, hereditary motor and sensory |
| RS1799849914 |
ASAH1
|
Health Risk |
Likely pathogenic |
— |
| RS1799857 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Diabetes mellitus, transient neonatal |
| RS1799858 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Permanent neonatal diabetes mellitus, Diabetes mellitus |
| RS1799871 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS1799910521 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS1799915649 |
SSBP1
|
Health Risk |
Pathogenic |
Optic atrophy 13 with retinal and foveal abnormalities, Optic atrophy 13 with retinal and foveal abnormalities |
| RS1799919744 |
CPLANE1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 17, Joubert syndrome 17 |
| RS1799939 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hirschsprung disease |
| RS1799945 |
HFE
|
Health Risk |
Conflicting classifications of pathogenicity; other |
Hemochromatosis type 1, Hereditary hemochromatosis |
| RS1799951 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1799954 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1799956 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1799963 |
F2
|
Health Risk |
Pathogenic/Likely pathogenic/Pathogenic, low penetrance/Established risk allele; risk factor |
Ischemic stroke, Pregnancy loss |
| RS1799969211 |
ASAH1
|
Health Risk |
Pathogenic |
— |
| RS1799970 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1799985749 |
PRPH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, PRPH2-related disorder |